Longevity Lens

A Look Inside the Innovation Powering Better Health for Longer

News

The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss

February 5, 2026

Abha Kundi*, Gayland O. Hethcoat II, Shoshana Golden

ArentFox Schiff Launches First-of-Its-Kind Longevity & Healthspan Industry Group

January 28, 2026

Gayland O. Hethcoat II, Karen Ellis Carr, Abha Kundi*, Jo-Ann Marchica, Marc E. Rivera, Michael Scarpati, Ph.D., Jill A. Steinberg, Michelle R. Bowling, Shoshana Golden, Blake K. Thelander*, Starshine S. Chun*

Lupo and Hethcoat Quoted on ArentFox Schiff Launch of Longevity & Healthspan Industry Group

January 28, 2026

Anthony V. Lupo, Gayland O. Hethcoat II

FDA Issues Updated Guidance on Low-Risk General Wellness Devices and Clinical Decision Support Software

January 14, 2026

Emily Cowley Leongini, Abha Kundi*

Featured

The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies

February 10, 2026

Gayland O. Hethcoat II, Abha Kundi*, Michelle R. Bowling

The longevity ecosystem sits at the crossroads of health care, life sciences, consumer wellness, artificial intelligence (AI), and other emerging technologies.

Search or View All Longevity Lens Content

Core Team

Karen Ellis Carr Portrait

Karen Ellis Carr

Partner and FDA Practice Leader

Gayland Hethcoat Portrait

Gayland O. Hethcoat II

Counsel

Abha Kundi Portrait

Counsel

Jo-Ann Marchica Portrait

Jo-Ann Marchica

Partner

Marc Rivera Portrait

Partner

Michael Scarpati, Ph.D. Portrait

Michael Scarpati, Ph.D.

Partner and AI & Emerging Technologies Industry Group Co-Leader

Jill Steinberg Portrait

Jill A. Steinberg

Partner

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.